openPR Logo
Press release

Asia-Pacific High Potency APIs Market: Key Vendors, Trends, Challenges, and Drivers to 2023

09-27-2018 04:55 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: RnRMarketResearch.com

The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

Click Here for Complete Report on High Potency APIs Market spread across 216 Pages, Profiling 12 Companies and Supported with 239 Tables and 42 Figures at http://www.rnrmarketresearch.com/high-potency-api-hpapi-market-by-type-innovative-generic-synthesis-synthetic-biotech-biologic-biosimilar-manufacturer-captive-merchant-therapy-oncology-glaucoma-hormonal-imbalance-global-forecast-to-2021-market-report.html .

Highly potent drugs represent a significant change in the way innovators are using small molecules to deliver new patient therapies. This shift toward the use of highly potent active pharmaceutical ingredients (HPAPIs) has not only led to a pipeline of more effective medicines that require lower doses and lead to fewer side effects, but also to new manufacturing challenges.

Introduction
1 Objectives of the Study
2 Market Definition
3 Study Scope
4 Markets Covered
5 Years Considered for the Study
6 Currency
7 Limitations
8 Market Stakeholders

The HPAPIs market is segmented into innovative and generic APIs. The generic HPAPIs segment is expected to register the highest growth rate during the forecast period. The impending patent cliff, increasing healthcare costs, and government initiatives to encourage the adoption of generics are the major factors driving the growth of this market segment.

Click Here for Sample Papers of High Potency APIs Market with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=835594 .

The HPAPIs market is segmented into captive HPAPI and merchant HPAPI manufacturers. In 2018, the captive HPAPI manufacturers segment is expected to account for the largest share of the market.

Premium Insights
1 High-Potency Active Pharmaceutical Ingredients Market: Overview
2 Global Market, By Type, 2018 vs 2023 (USD Billion)
3 Global Market, By Type of Synthesis, 2018 vs 2023 (USD Billion)
5 Global Market, By Therapeutic Area (2018–2023)
6 Geographical Snapshot of the Global Market

Click Now for More Details on “High Potency APIs /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023”report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=835594 .

In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR of 11.8% during the forecast period. Factors such as growth in geriatric population, high prevalence of chronic and lifestyle diseases, increase in disposable income, prevalence of lifestyle- and age-related diseases.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 31%; Tier 2 -49%; Tier 3 - 20%
• By Designation: C-level- 28%; D-level- 19%; Others- 53%
• By Region: North America-31%; Europe-33%;Asia Pacific-19%; Rest of the World-17%

The report provides an overview of the HPAPIs market. It aims at estimating the market size and future growth potential of this market across different segments such type, type of manufacturer, type of synthesis, therapeutic application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles.

Target Audience for this Report:
• Manufacturers of HPAPI
• Distributors and suppliers of HPAPIs
• Potential investors in the HPAPI market
• Pharmaceutical companies
• Biotechnology companies
• Contract manufacturing organizations
• Life science research centers
• Healthcare payers

Order This Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=835594 .

About Us:-
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.
With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific High Potency APIs Market: Key Vendors, Trends, Challenges, and Drivers to 2023 here

News-ID: 1267968 • Views:

More Releases from RnRMarketResearch.com

Global Polyglycolic Acid Market Key Players Kureha(JP), Samyang Biopharm(KR), Me …
The global Polyglycolic Acid market was valued at 1158.31 Million USD in 2021 and will grow with a CAGR of 4.99% from 2021 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types,
RF Semiconductor Market Expected to Grow at 26.2 Billion In Revenue by 2025
RF Semiconductor Market Expected to Grow at 26.2 Billion In Revenue by 2025
According to Market Study Report, RF Semiconductor Market provides a comprehensive analysis of the RF Semiconductor Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape technological trends and emerging opportunities of global industry. This report also provides market landscape and market share information in the RF Semiconductor Market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample Copy in PDF
24.7% Growth Rate for Social and Emotional Learning (SEL) Market by 2024 | Global Key Players like Everyday Speech, Peekapak, Nearpod, EVERFI and Others.
24.7% Growth Rate for Social and Emotional Learning (SEL) Market by 2024 | Globa …
The Global report on "Social and Emotional Learning (SEL) Market" delivering key insights and providing a competitive advantage to clients through a detailed report. The report also details the information about the global market status, growth rate, future trends, market drivers, challenges, opportunities and porter's forces analysis with respect to these elements. Get Instant Free Sample Copy in PDF Format @ https://www.rnrmarketresearch.com/contacts/request-sample?rname=2915432 The Social and Emotional Learning (SEL) Market size is
Healthcare Business Intelligence Market Reaching to US$ 8.9 Billion Revenue to 2023 Overview by Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia) and BOARD International (Switzerland) Key Players
Healthcare Business Intelligence Market Reaching to US$ 8.9 Billion Revenue to 2 …
The healthcare business intelligence market dominated by OLAP & visualization, performance management, and query & reporting. Report provides a picture of the global healthcare business intelligence market. Get Free Sample Papers of Healthcare Business Intelligence Market with 194 Pages and 12 Company Profiles Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=175696 . Healthcare business intelligence market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% during

All 5 Releases


More Releases for HPAPI

HPAPI Market: Opportunities and Challenges
The global HPAPIs Market is projected to register a CAGR of 8.7% during the forecast period (2018-23). The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies and growing focus on precision medicine. However, factors such as the requirement of large investments, discrepancies in HPAPI banding
New Technologies for HPAPI Manufacturing and Containment
SMI Reports: With new technologies becoming available for the pharmaceutical industry, the HPAPI market is utilising these new innovations to simplify manufacturing processes reducing powder exposure and allowing a semi-continuous production. At this year's HPAPI USA Conference emerging manufacturing technologies will be one of the key points to be discussed along with containment issues, disaster management, Oncology Antibody-Drug Conjugates (ADCs) and staff training procedures. Key highlights include: Alternative HPAPI manufacturing technologies to
The Latest Innovations in HPAPI Manufacturing Technologies
SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, along with cleaning and cross contamination requirements. Keith Jensen, Owner and Consultant at Keith Jensen Consulting, previously at Novartis-MIT Center for Continuous Manufacturing, discusses alternative HPAPI manufacturing technologies to reduce powder exposure and improve safety enabling continuous manufacturing. Other
HPAPI 2019 Conference: Exclusive Interview Released with AstraZeneca
Peter Marshall from AstraZeneca will be speaking at SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference which will take place in London on 13th-14th May. He will be discussing the latest developments in the industry with a specific focus on the principles of pharmaceutical containment in isolator design. Ahead of the conference, SMi had interviewed him where he gave a taster of what he will be discussing. Peter said: “The
The Latest Techniques in HPAPI Facility Design
Amongst the myriad of potential pitfalls for the Highly Potential Active Pharmaceutical Ingredients (HPAPI) industry there is a requirement for all parties involved to have a blueprint in place to ensure all containment procedures are followed correctly. Yet, there is also a need to ensure that operations are maintained at the highest standards. At SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients Conference these issues will be discussed along with
HPAPI (High Potency Active Pharmaceutical Ingredients) Market Report 2018: Segme …
Global HPAPI (High Potency Active Pharmaceutical Ingredients) market research report provides company profile for Lonza, Novasep, Thermofisher Scientific, Alkermes, Cambrex, Dishman, Dr. Reddy’S and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report